About Reach Separations
Reach Separations is a company based in Nottingham (United Kingdom) founded in 2011 was acquired by CatSci in June 2024. The company has 16 employees as of January 31, 2022. Reach Separations offers products and services including Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification. Reach Separations operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and PharmaFluidics, among others.
- Headquarter Nottingham, United Kingdom
- Employees 16 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reach Separations Limited
- Date of Incorporation 15 Nov, 2011
- Jurisdiction NOTTINGHAM
-
Annual Revenue
Not available
-
Net Profit
$343.94 K (USD)-52as on Jan 31, 2023
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Royal Society of Chemistry
& 1 more
-
Employee Count
16
as on Jan 31, 2022
-
Acquired by
CatSci
(Jun 25, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reach Separations
Reach Separations offers a comprehensive portfolio of products and services, including Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification.
Provides rapid analysis and purification for various samples
Offers purification services for targeted molecular compounds
Purifies substances for pharmaceutical applications
Handles purification of peptides for research and industry
Funding Insights of Reach Separations
Investors in Reach Separations
Reach Separations has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Royal Society of Chemistry and CatSci.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A community focused on science & technology
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to pharmaceutical clients worldwide.
|
Locked | Locked | Locked |
Investor details for Reach Separations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reach Separations
Investment portfolio details for Reach Separations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reach Separations
Detailed financials for Reach Separations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reach Separations Comparisons
Peer comparison for Reach Separations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reach Separations
Reach Separations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and PharmaFluidics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of proprietary filtration solutions for life science
|
|
| Locked | Locked | Locked |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
Detailed competitors of Reach Separations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reach Separations
Complete news archive for Reach Separations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reach Separations
Reach Separations was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Reach Separations is headquartered in Nottingham, United Kingdom.
As of Jan 31, 2022, the latest employee count at Reach Separations is 16.
Reach Separations uses HPLC (High-Performance Liquid Chromatography) and SFC (Supercritical Fluid Chromatography) technologies to offer small molecule analysis and purification services to the pharmaceutical, agrochemical and fine chemical sectors. The company claims to have the expertise for both chiral and achiral purification and separation. They can use both HPLC and SFC in parallel. Reach Separations claims to use a wide selection of columns from a variety of different Chiral Stationary Phase (CSP) manufacturers in its chiral screens as compared to other screening methodologies which only employ one brand of the column. They have 5 preparatives HPLC and 5 preparative SFCs for chiral and 3 preparatives HPLC and SFC capabilities for achiral separations. The company also has capabilities such as UHPLC-MS system with diode array detection (DAD) for providing high-quality final purity data.
Reach Separations's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Reach Separations offers Analytical Services, PROTACs and Molecular Glue Purification, Oligonucleotide Drug Substances Purification, and Peptide Purification.
Reach Separations has 2 investors. Key investors include Royal Society of Chemistry, and CatSci.